• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

时间在范围内与 1 型糖尿病成人的糖尿病视网膜病变事件相关:一项纵向研究。

Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study.

机构信息

Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Jaeb Center for Health Research, Tampa, FL, USA.

出版信息

Diabetes Technol Ther. 2024 Apr;26(4):246-251. doi: 10.1089/dia.2023.0486. Epub 2024 Feb 13.

DOI:10.1089/dia.2023.0486
PMID:38133643
Abstract

To evaluate the association between continuous glucose monitoring (CGM)-based time in various ranges and the subsequent development of diabetic retinopathy (incident DR) in adults with type 1 diabetes. Between June 2018 and March 2022, adults with type 1 diabetes with incident DR or no retinopathy (control) were identified. CGM data were collected retrospectively for up to 7 years before the date of eye examination defining incident DR or control. Associations between incident DR and CGM metrics were evaluated using logistic regression models. This analysis included 71 adults with incident DR (mean age 27 years, 52% females, and mean diabetes duration 15 years) and 92 adults without DR (mean age 38 years, 48% females, and mean diabetes duration 20 years). Adjusting for age, diabetes duration, and CGM type, each 0.5% increase in glycated hemoglobin (HbA1c), 10 mg/dL increase in mean glucose, 5% decrease in time in target range 70-180 mg/dL (TIR), 5% decrease in time in tight target range 70-140 mg/dL (TITR), and 5% increase in time above 180 mg/dL (TAR) were associated with 24%, 22%, 18%, 28%, and 20% increase in odds of incident DR, respectively. Spearman correlations of TIR, TITR, TAR, and mean glucose with each other were all ≥0.97. Similar to HbA1c, TIR, TITR, TAR, and mean glucose were associated with increased risk for incident DR in adults with type 1 diabetes. These CGM metrics are highly correlated indicating that they provide similar information on glycemic control and diabetic retinopathy risk.

摘要

评估连续血糖监测(CGM)在不同范围内的时间与 1 型糖尿病成人中糖尿病视网膜病变(DR)发病的相关性。在 2018 年 6 月至 2022 年 3 月期间,确定了患有 1 型糖尿病且有或无 DR(对照组)的成人。收集了在眼部检查确定 DR 发病或对照组前长达 7 年的 CGM 数据。使用逻辑回归模型评估 DR 发病与 CGM 指标之间的相关性。这项分析包括 71 名患有 DR 发病的成年人(平均年龄 27 岁,女性占 52%,糖尿病病程 15 年)和 92 名无 DR 的成年人(平均年龄 38 岁,女性占 48%,糖尿病病程 20 年)。调整年龄、糖尿病病程和 CGM 类型后,糖化血红蛋白(HbA1c)每增加 0.5%、平均血糖增加 10mg/dL、目标范围 70-180mg/dL(TIR)时间减少 5%、严格目标范围 70-140mg/dL(TITR)时间减少 5%和血糖高于 180mg/dL(TAR)时间增加 5%,与 DR 发病的几率分别增加 24%、22%、18%、28%和 20%相关。TIR、TITR、TAR 和平均血糖之间的 Spearman 相关系数均≥0.97。与 HbA1c 相似,TIR、TITR、TAR 和平均血糖与 1 型糖尿病成人中 DR 发病风险增加相关。这些 CGM 指标高度相关,表明它们提供了关于血糖控制和糖尿病视网膜病变风险的相似信息。

相似文献

1
Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study.时间在范围内与 1 型糖尿病成人的糖尿病视网膜病变事件相关:一项纵向研究。
Diabetes Technol Ther. 2024 Apr;26(4):246-251. doi: 10.1089/dia.2023.0486. Epub 2024 Feb 13.
2
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.1型糖尿病患者慢性并发症与血糖严格控制时间及血糖达标时间的相关性:一项回顾性横断面真实世界研究
Diabetologia. 2024 Aug;67(8):1527-1535. doi: 10.1007/s00125-024-06171-y. Epub 2024 May 24.
3
Use of Diabetes Technologies and Retinopathy in Adults With Type 1 Diabetes.糖尿病技术的应用与 1 型糖尿病成人患者的视网膜病变
JAMA Netw Open. 2024 Mar 4;7(3):e240728. doi: 10.1001/jamanetworkopen.2024.0728.
4
Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.连续血糖监测评估的时间范围内与 2 型糖尿病患者糖尿病视网膜病变的关系。
Diabetes Care. 2018 Nov;41(11):2370-2376. doi: 10.2337/dc18-1131. Epub 2018 Sep 10.
5
Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.连续血糖监测指标(平均血糖、血糖超标时间和血糖达标时间)优于糖化血红蛋白,可用于评估治疗效果。
Diabetes Obes Metab. 2023 Feb;25(2):596-601. doi: 10.1111/dom.14906. Epub 2022 Dec 1.
6
Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.连续血糖监测评估的血糖变异性与成人隐匿性自身免疫糖尿病和 2 型糖尿病患者糖尿病视网膜病变的风险。
J Diabetes Investig. 2019 May;10(3):753-759. doi: 10.1111/jdi.12957. Epub 2018 Nov 7.
7
Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients.比较 2 型糖尿病患者的血糖时间范围和血糖曲线下面积与糖尿病视网膜病变风险的关系。
J Diabetes Investig. 2022 Sep;13(9):1543-1550. doi: 10.1111/jdi.13811. Epub 2022 May 6.
8
Continuous glucose monitoring metrics following sub-Tenon's injection of triamcinolone acetonide for diabetic macular edema.用于治疗糖尿病性黄斑水肿的曲安奈德球后注射后的连续血糖监测指标
Graefes Arch Clin Exp Ophthalmol. 2024 Feb;262(2):449-456. doi: 10.1007/s00417-023-06275-y. Epub 2023 Oct 21.
9
Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.连续血糖监测(CGM)评估的血糖变异性与 1 型和 2 型糖尿病患者糖尿病视网膜病变的相关性。
Acta Diabetol. 2013 Jun;50(3):437-42. doi: 10.1007/s00592-013-0459-9. Epub 2013 Feb 16.
10
Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.是否是时候超越 TIR 而采用 TITR 了?来自超过 20000 名 1 型和 2 型糖尿病患者使用连续血糖监测的真实世界数据。
Diabetes Technol Ther. 2024 Mar;26(3):203-210. doi: 10.1089/dia.2023.0565.

引用本文的文献

1
Diabetic retinal disease.糖尿病视网膜病变
Nat Rev Dis Primers. 2025 Aug 28;11(1):62. doi: 10.1038/s41572-025-00646-x.
2
Validation of a predictive calculator for optimal glycemic control and time-in-tight-range following CGM sensor placement in type 1 diabetes and pancreatic diabetes: a prospective study.1型糖尿病和胰腺性糖尿病患者在连续血糖监测(CGM)传感器置入后用于优化血糖控制和血糖处于目标范围内时间的预测计算器的验证:一项前瞻性研究。
Endocrine. 2025 Aug 26. doi: 10.1007/s12020-025-04385-7.
3
Assessment of Microvascular Disturbances in Children with Type 1 Diabetes-A Pilot Study.
1型糖尿病患儿微血管病变的评估——一项初步研究
Biosensors (Basel). 2025 Jul 8;15(7):439. doi: 10.3390/bios15070439.
4
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.自动胰岛素输送系统的研究空白、挑战与机遇
J Diabetes Sci Technol. 2025 Jul;19(4):937-949. doi: 10.1177/19322968251338754. Epub 2025 Jul 1.
5
Effectiveness and safety of AI-driven closed-loop systems in diabetes management: a systematic review and meta-analysis.人工智能驱动的闭环系统在糖尿病管理中的有效性和安全性:一项系统评价和荟萃分析。
Diabetol Metab Syndr. 2025 Jun 23;17(1):238. doi: 10.1186/s13098-025-01819-0.
6
Future of diabetic foot risk: Unveiling predictive continuous glucose monitoring biomarkers.糖尿病足风险的未来:揭示预测性连续血糖监测生物标志物。
World J Diabetes. 2025 Jun 15;16(6):107006. doi: 10.4239/wjd.v16.i6.107006.
7
Long-Term Performance of Two Systems for Automated Insulin Delivery in Adults With Type 1 Diabetes: An Observational Study.1型糖尿病成人患者两种自动胰岛素给药系统的长期性能:一项观察性研究。
Endocrinol Diabetes Metab. 2025 May;8(3):e70043. doi: 10.1002/edm2.70043.
8
Continuous glucose monitoring guides glucagon-like peptide 1-based therapy use and optimization in people with type 2 diabetes.持续葡萄糖监测指导2型糖尿病患者使用和优化基于胰高血糖素样肽1的治疗。
J Family Med Prim Care. 2025 Feb;14(2):790-795. doi: 10.4103/jfmpc.jfmpc_773_24. Epub 2025 Feb 21.
9
Time in range-A new gold standard in type 2 diabetes research?血糖达标时间——2型糖尿病研究的新金标准?
Diabetes Obes Metab. 2025 May;27(5):2342-2362. doi: 10.1111/dom.16279. Epub 2025 Feb 25.
10
Hybrid closed loop and intensive insulin delivery technology: Reviewing the effect of improving 'time in range' glucose levels on diabetic retinopathy.混合闭环与强化胰岛素输注技术:探讨改善血糖处于目标范围内的时间对糖尿病视网膜病变的影响
Eye (Lond). 2025 Apr;39(6):1028-1030. doi: 10.1038/s41433-025-03730-4. Epub 2025 Feb 20.